Navigation Links
ENDOPATH Xcel Bladeless Trocars

ProductsENDOPATH Xcel Bladeless Trocars
Company Ethicon, Inc.
Item ENDOPATH Xcel Bladeless Trocars
Features 
  • Minimized patient trauma: Designed to protect abdominal wall tissues and vessels from trauma.
  • Simplified closure: Post-procedure fascial suturing may not be routinely required.
  • Direct visualization: Optical tip eliminates blind entry by enabling visualization of tissue layers during insertion.
  • Increased abdominal wall fixation: Minimal tissue trauma means tissue fibers maintain natural resiliency, tightly holding cannula in place.
  • Every part works together.
  • Ergonomic Housing means more surface area of the trocar housing is in contact with the surgeons hand, which provides more control during the insertion of the trocar.
  • Color-Coded Symbol indicates blade type and trocar size. This simple visual cue allows the surgical team to quickly identify each trocar.
  • Universal Seal ends the need for reducer caps, allowing a wide-range of instrument sizes to be passed through the trocar. This design also creates less drag and maintains constant insufflation.
  • Duckbill Seal replaces the flapper valve, which facilitates the removal of specimens and ensures constant insufflation whenever an instrument is not in the trocar.
  • Recessed Stopcock Valve minimizes inadvertent opening/closing of the valve during surgery, reducing overall procedure time.
  • Low-Profile Housing enables further instrument reach since the top of the trocar is closer to the abdominal wall. This reduces the need to stabilize the trocar, facilitating one-handed insertion/removal of instruments.
  • Funnel Lead-In at the entrance to the housing allows for one-handed instrument exchange since the housing directs the end of the instrument into the housing/cannula.
  • New Stability Thread Design provides greater fixation to the abdominal wall.
  • Description At Ethicon Endo-Surgery, we believe that the trocar should be a seamless part of any procedure, facilitating instrument precision and speeding the process. So we spent over three years designing a trocar that meets the needs of the most demanding surgeons.

    Introducing the ENDOPATH Xcel - The only trocar that affords the surgeon unencumbered, hassle-free, laparoscopic access.

    The ENDOPATH XCEL Bladeless Trocar has applications in abdominal, thoracic, and gynecologic minimally invasive procedures to establish a path of entry for Endoscopic instruments. The trocar may be used with or without visualization for primary and secondary insertions.

    This is what a trocar should be: an access device with a more durable seal that ensures constant insufflation. An access device that enables one-handed instrument exchange, and reduces hang-ups. An access device that increases abdominal wall fixation by 89%and offers better tactile sensation.

    With a simple twisting motion, combined with downward pressure, the bladeless tip separates tissue, rather than cutting it. The result: a smaller fascial defect, and less trauma to the abdominal wall and vessel.
    Info Ethicon, Inc.
    Customer Service: (800) 4-ETHICON
    Web site: http://www.ethicon.com/

    Related medicine products :

    1. ENDOPATH Blunt Tip Dissector
    2. ENDOPATH 5DCS Scissors
    3. ENDOPATH® Xcel™ Blunt Tip Trocars
    4. ENDOPATH TRISTAR Trocars
    5. ENDOPATH Large-Port Trocars
    6. ENDOPATH Dilating Tip Trocars
    7. ENDOPATH Surgical Thoracic Trocar Sleeve with Rounded Tip Obturator
    8. ENDOPATH ETS45 Endoscopic Linear Cutters
    9. ENDOPATH ETS-Flex45 Endoscopic Articulating Linear Cutters
    10. ENDOPATH ETS Compact-Flex45 Articulating Linear Cutters
    11. ENDOPATH ETS Compact-Flex45 No-Knife Articulating Linear Staplers
    mobileMICROMEDEX™ gives physicians, pharmacists, and other healthcare professionals reliable clinical information to help support and confirm treatment decisions. Clinicians can trust the data i
    Focuses primarily on the drugs used for treatment and symptom management for colorectal cancer.
    Portable Drug Companion is a comprehensive, authoritative drug reference to chose from over 5,500 entries, with overdose management, Canadian drug names, OTC and herbal remedies. This "Mini-Suite" of
    The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy.
    Medicine Products:
    (Date:12/3/2008)...sters feel better mentally, physically, researcher...ews) -- Overweight kids may be able to work out th... A study of sedentary but otherwise healthy 7- to ...and anger issues by taking part in a 10- to 15-wee...ng applied to children across lines such as race, ...
    (Date:12/3/2008)...ing less responsible uses, claims, experts say , ...Expensive, sham stem cell therapies are being hawk...t, experts say. , In response, the leading orga...ed guidelines to steer research in the field towar...earch is progressing so rapidly and has sparked a ...
    (Date:12/3/2008)...Interleukin-12 is a naturally occurring protein es...mune system. Having either too much or too little ...of many diseases, including some cancers and auto-...matoid arthritis. In turn, modulating interleukin-...itions. , In an effort to create a new and cost-...
    (Date:12/3/2008)...tive osteoporosis treatment could soon be a realit... accurately at which point someone needs further d...rranted, has been developed by The National Osteop... relying primarily on Bone Mineral Density (BMD) m... do, their approach takes into account both the ri...
    Breaking Medicine News(10 mins):Health News:Bogus Stem Cell Therapies Sold on Internet 2Health News:Bogus Stem Cell Therapies Sold on Internet 3Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 2Health News:Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants 3Health News:WHO tool helps target bone treatment 2
    ...the only bird to have shown the H5N1 virus bird fl...ith the infection and health // officials are now ...t a native species. This has calmed fears of a pan...f veterinary officers admitted that they were unaw...
    ...e given to a condition characterized by a “thick” ...ugh it remains one of the toughest // conditions f...e condition affects women more than men and is pro...e. It may also be seen in patients with type 2 di...
    ...ed smuggled bird and poultry parts or in whole.// ...ts found bags of duck feet. Also a similar raid at...million packages of chicken meat smuggled from Chi...is increasing evidence that a thriving internation...
    ...at the University of Alberta people who do not wea...mpared to people who wear them. // In addition Dr.... Research Lab states that young attractive people ...most neglectful child caretakers of all. His conc...
    Other Medicine News:Health News:Smuggling could also be a carrier to bird flu spread. 2Health News:Get that wedding ring on if you want to be branded a responsible parent! 2
    (Date:11/27/2008)...ty of acute lymphoblastic leukemia relapse cases a...agnosis , , MEMPHIS, Tenn., Nov. 27 /PRNews...n,s Research Hospital have identified distinctive ...th acute lymphoblastic leukemia (ALL) that cause r...treatments for ALL relapse in children and, ultima...
    (Date:11/26/2008)...ity, automation and intelligent clinical applicati...ll new level , , CHICAGO, Ill., Nov. 26 /PR...w.siemens.com/healthcare ) highlights the ACUSON ...), the world,s first multi-use, automated volume ...ssembly and Annual Meeting of the Radiological Soc...
    (Date:11/25/2008)...ove recovery , , Audio and Web Video Resour...ayo Clinic News Blog. Please see the bottom of thi...Minn., Nov. 25 A Mayo C...n,t think they,re having a stroke -- and as a resu...n worsens. The findings appear in the current issu...
    (Date:11/25/2008)...dents against expanding statin use broadly in wake....J., Nov. 25 JUPITER, a clinical t...ascular risk of healthy patients with elevated CRP...adults, according to a national poll directed at h...part in the online poll conducted by medical news ...
    Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 1NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 2NeurogesX to Report Third Quarter 2007 Financial Results on November 14 2007 5891 3Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 1742 1Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 1742 2Religion and psychology 5886 1UBC researchers discover instruction manual that tells cancers how to hide from immune system 5882 1
    ..., 4th May 2007 - CeNeS Pharmaceuticals plc,(LSE: C..., notes,the publication of an independent study in...s Phase II NMDA antagonist, CNS 5161. CeNeS,is dev...opathic,pain. The independent study builds on the ...61. , In the study reported in ,Synapse, Dr Anat ...
    ...BUSINESS WIRE)--May 4, 2007 - New data from a,rand...on of,COPAXONE(R) (glatiramer acetate injection) a...T1 Gadolinium (Gd)-enhancing lesions,of the brain ...apsing-remitting multiple sclerosis (RRMS), as mea...d to those receiving,COPAXONE(R) alone. Additional...
    Other Medicine Technology:Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5